Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Vanda Pharmaceuticals Inc. (VNDA)

28.8   -1.23 (-4.1%) 01-23 16:00
Open: 30.06 Pre. Close: 30.03
High: 30.65 Low: 28.52
Volume: 659,393 Market Cap: 1511M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 30.682 - 30.849 30.849 - 30.988
Low: 28.131 - 28.331 28.331 - 28.497
Close: 28.498 - 28.804 28.804 - 29.058

Technical analysis

as of: 2019-01-23 4:32:27 PM
Overall:       
Stoxline posted a STRONG SELL today, downgraded from higher rating. This stock seems to be very strong for short side. So you may continue to hold the short positions or sell your long positions. It is relatively safe to short or sell, downward move is expected.
Target: Six months: 36.56     One year: 42.70
Support: Support1: 26.28    Support2: 23.17
Resistance: Resistance1: 31.30    Resistance2: 36.56
Pivot: 28.86
Moving Average: MA(5): 30.17     MA(20): 28.00
MA(100): 23.51     MA(250): 20.22
MACD: MACD(12,26): 1.19     Signal(9): 1.11
Stochastic oscillator: %K(14,3): 77.18     %D(3): 87.83
RSI: RSI(14): 54.61
52-week: High: 33.44  Low: 13.88  Change(%): 83.4
Average Vol(K): 3-Month: 71988  10-Days: 55431

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
VNDA has closed above bottom band by 48.9%. Bollinger Bands are 0.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2019-01-11T17:01:16-05:00
Does The Bull Survive? Stock Market Outlook 2019

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 52.45
Shares Float (M) 50.31
% Held by Insiders
% Held by Institutions 152.50
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS 0.240
EPS Est. Current Year -0.430
EPS Est. Next Year -0.180
EPS Est. Next Quarter -0.110
Forward EPS 0.580
Book Value (p.s.) 6.180
PEG Ratio 1.34
Profit Margin 10.60
Operating Margin 5.66
Return on Assets (ttm) 5.1
Return on Equity (ttm) 6.7
Qtrly Rev. Growth 18.9
Gross Profit (p.s.) 0.753
Sales Per Share
EBITDA (p.s.) -0.026
Qtrly Earnings Growth
Operating Cash Flow (M) 18.19
Levered Free Cash Flow (M) -38.20

Stock Valuations

P/E 120.00
P/E Growth Ratio -0.04
P/BV 4.66
P/S 401744640.00
P/CF 83.04

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.